Cloutier Daniel Danny 4
4 · BRAIN SCIENTIFIC INC. · Filed Aug 25, 2022
Insider Transaction Report
Form 4
Cloutier Daniel Danny
Director
Transactions
- Award
Options to Purchase Common Stock
2022-02-03+362,069→ 362,069 totalExercise: $0.29Exp: 2031-12-11→ Common Stock (362,069 underlying) - Award
Options to purchase Common Stock
2022-08-19+304,608→ 304,608 totalExercise: $0.12Exp: 2027-08-19→ Common Stock (304,608 underlying)
Footnotes (2)
- [F1]The options were initially issued to Mr. Cloutier pursuant to a stock option agreement, dated December 10, 2021, whereby Mr. Cloutier was issued 61,140 options to purchase shares of common stock of the Issuer with an exercise price of $0.21. On February 3, 2022, the Issuer and Mr. Cloutier entered into an amended stock option agreement (the "Amendment") whereby (i) the number of options issued to Mr. Cloutier was amended to 362,069, and (ii) the exercise price was amended to $0.29. Pursuant to the Amendment, the options shall vest and become exercisable pursuant to the following schedule: 46,623 options vested and became exercisable on December 31, 2021, 89,277 options vested and became exercisable on March 31, 2022; 90,269 options shall become exercisable on June 30,2022, 91,261 options shall become exercisable on September 30,2022; and 44,639 options shall become exercisable on December 31, 2022.
- [F2]304,608 stock options (the "Options") were granted to Mr. Kukekov on August 19, 2022 (the "Date of Grant"), pursuant to the Brain Scientific 2022 Stock Incentive Plan. The Options shall vest and become exercisable on the following schedule: (i) 61,552 Options shall vest immediately, (ii) 69,444 Options shall vest on August 30, 2022, (iii) 69,444 Options shall vest on September 30, 2022, (iv) 69,444 Options shall vest on October 30, 2022, and (v) 34,724 Options shall vest on November 15, 2022.